Coral Labs.

Coral_Labs.30 Apr 2024

Pharmaceuticals

₹

-5.15 (-1.34%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Coral Labs.

Coral Labs.

Pharmaceuticals

Coral_Labs.30 Apr 2024

₹

-5.15 (-1.34%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
28-May-2019	D	Coral Laboratories Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 28, 2019, inter alia, has recommended Dividend @ 20% i.e. Rs. 2/- per equity share of face value Rs. 10/- each for the year 2018-19, Subject to approval of Shareholders of the Company on ensuing Annual General Meeting.	19-Sep-2019
23-May-2018	D	Coral Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 23, 2018, inter alia, has recommended Dividend @ 20% i.e. Rs. 2/- per equity share of face value Rs. 10/- each for the year 2017- 18, Subject to approval of Shareholders of the Company on ensuing Annual General Meeting.	18-Sep-2018
26-May-2017	D	Coral Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2017, inter alia, has recommended Dividend @ 50% i.e. Rs. 5/- per equity share of face value Rs. 10/- each for the year 2016-17, Subject to approval of Shareholders of the Company on ensuing Annual General Meeting.	11-Sep-2017
30-May-2016	D	Coral Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2016, inter alia, has proposed dividend @ 30% i.e. Rs. 3 per Equity share of face value Rs. 10 each for FY 2015-16.	16-Sep-2016
29-May-2015	D	Coral Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2015, inter alia, has recommended Dividend @25% i.e. Rs. 2.5/- per equity share of Rs. 10/- each for the financial year 2014-15 subject to approval of Shareholders of the Company at the ensuing Annual General Meeting.	08-Sep-2015
30-May-2014	D	Coral Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has recommended Dividend @ 20% i.e. Rs. 2/- per equity share of Rs. 10/- each tar the year 2013-14.	16-Sep-2014
30-May-2013	D	Coral Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has recommended Final Dividend @ 15 % i.e. Rs. 1.50/- per equity share of Rs. 10/- each for the year 2012-2013.	18-Sep-2013
14-Aug-2012	D	Coral Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 14, 2012, inter alia, recommended Dividend @ 15 % i.e. Rs. 1.50/-. per equity share of Rs. 10/- each.	17-Sep-2012
12-Aug-2011	D	Coral Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2011, inter alia, has recommended dividend @ 15% i.e. Rs. 1.50 per Equity Shares of Rs. 10/-.	19-Sep-2011
31-Aug-2010	D	Coral Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 31, 2010, inter alia, has recommended Dividend @ 15% i.e. Rs. 1.50 per Equity Shares of Rs. 10/-.	17-Sep-2010
02-Sep-2009	D	12% Dividend Coral Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 29, 2009, inter alia, has recommended a dividend @ 12% for the year 2008-09 which is Rs. 1.20 per Equity Share of face value Rs. 10/- each in the Current Share Capital base as on March 31, 2009, subject to the approval of shareholders. (As Per BSE Announcement Website dated on 03.09.2009)	17-Sep-2009
30-Jun-2008	D	Coral Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 30, 2008, inter alia, has recommended dividend of 10% which is Rs 1/- per Equity share of the Face value of Rs 10/-each.	19-Sep-2008
29-Aug-2007	D	Coral Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 29, 2007, inter alia, has recommended a Dividend at 15% (i.e. Re 1.50 per Equity Share) for the year 2006-07.	20-Sep-2007
19-Apr-2006	D	15% Dividend	20-Sep-2005
11-Jul-2023	BC	Intimation under Reg 30 of SEBI (LODR) 2015 for re-appointment of Mr. Saurabh Shah as Independent Director of the Company for a second Term of five years commencing from 28th May 2024 to 27th May 20	28-May-2024
19-Apr-2024	BC	CORAL LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2024 inter alia to consider and approve Appointment of Company Secretary Ap	24-Apr-2024
24-Apr-2024	BC	Appointment of Mrs. Ruchi Pipara as Company Secretary and Compliance Officer	24-Apr-2024
04-Apr-2024	BC	Appointment of Cost Auditor The Company through this corrigendum wishes to bring to your notice, certain changes in Announcement of Appointment of Cost Auditor dated April 4, 2024. (As Per BSE	04-Apr-2024
15-Mar-2024	BC	Ms. Shifa Memon has resigned from the post of Company Secretary, Compliance Officer and Key Managerial Personnel of the company. Details under regulation 30 of the SEBI LODR are attached.	14-Mar-2024

Announcement Date28-May-2019

Ex Dividend Date19-Sep-2019

Dividend(%)20

Announcement Date23-May-2018

Ex Dividend Date18-Sep-2018

Dividend(%)20

Announcement Date26-May-2017

Ex Dividend Date11-Sep-2017

Dividend(%)50

Announcement Date30-May-2016

Ex Dividend Date16-Sep-2016

Dividend(%)30

Announcement Date29-May-2015

Ex Dividend Date08-Sep-2015

Dividend(%)25

Announcement Date30-May-2014

Ex Dividend Date16-Sep-2014

Dividend(%)20

Announcement Date30-May-2013

Ex Dividend Date18-Sep-2013

Dividend(%)15

Announcement Date14-Aug-2012

Ex Dividend Date17-Sep-2012

Dividend(%)15

Announcement Date12-Aug-2011

Ex Dividend Date19-Sep-2011

Dividend(%)15

Announcement Date31-Aug-2010

Ex Dividend Date17-Sep-2010

Dividend(%)15

Announcement Date02-Sep-2009

Ex Dividend Date17-Sep-2009

Dividend(%)12

Announcement Date30-Jun-2008

Ex Dividend Date19-Sep-2008

Dividend(%)10

Announcement Date29-Aug-2007

Ex Dividend Date20-Sep-2007

Dividend(%)15

Announcement Date19-Apr-2006

Ex Dividend Date20-Sep-2005

Dividend(%)15

No Rights has been declared by Coral_Labs.

Book Closure

Record Date	Split Date	Purpose
28-May-2024	-	Intimation under Reg 30 of SEBI (LODR) 2015 for re-appointment of Mr. Saurabh Shah as Independent Director of the Company for a second Term of five years commencing from 28th May 2024 to 27th May 20
24-Apr-2024	-	CORAL LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2024 inter alia to consider and approve Appointment of Company Secretary Ap
24-Apr-2024	-	Appointment of Mrs. Ruchi Pipara as Company Secretary and Compliance Officer
04-Apr-2024	-	Appointment of Cost Auditor The Company through this corrigendum wishes to bring to your notice, certain changes in Announcement of Appointment of Cost Auditor dated April 4, 2024. (As Per BSE
14-Mar-2024	-	Ms. Shifa Memon has resigned from the post of Company Secretary, Compliance Officer and Key Managerial Personnel of the company. Details under regulation 30 of the SEBI LODR are attached.

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Coral Laboratories Ltd ₹378.70(-5.15/-1.34%)	378.70	-5.15	135.20	45.71	14.76	0.79
Astrazeneca Pharma India Ltd ₹5,341.25(-214.85/-3.87%)	5,341.25	-214.85	13,353.13	68.03	83.72	20.39
Bliss GVS Pharma Ltd ₹123.70(-0.75/-0.60%)	123.70	-0.75	1,295.03	60.30	18.97	1.32
Cipla Ltd ₹1,401.20(-6.35/-0.45%)	1,401.20	-6.35	113,132.18	52.94	34.40	4.37
Abbott India Ltd ₹26,415.75(+138.15/0.53%)	26,415.75	+138.15	56,133.47	18.05	49.00	18.06
Amrutanjan Health Care Ltd ₹697.95(-11.45/-1.61%)	697.95	-11.45	2,017.82	15.18	45.86	7.70

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	18.08	23.15	13.55	11.44	24.73	25.70
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	18.08	23.15	13.55	11.44	24.73	25.70
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	1.44	1.81	1.29	1.16	1.54	2.21
Total Income	19.52	24.96	14.84	12.60	26.27	27.90
Total Expenditure	16.05	17.00	11.81	13.52	23.88	21.38
PBIDT	3.47	7.96	3.03	-0.92	2.39	6.52
Interest	0.00	0.00	0.00	0.02	0.11	0.11
PBDT	3.47	7.96	3.03	-0.94	2.28	6.41
Depreciation	0.49	0.44	0.55	0.68	0.50	0.50
Tax	0.80	1.50	0.63	-0.63	0.90	1.00
Deferred Tax	0.02	0.02	0.02	-0.10	0.02	0.02
Reported Profit After Tax	2.16	6.00	1.84	-0.89	0.86	4.89
Extra-ordinary Items	-0.05	0.00	0.00	0.00	0.02	0.00
Adjusted Profit After Extra-ordinary item	2.21	6.00	1.84	-0.89	0.84	4.89

EPS (Unit Curr.)	6.04	16.81	5.16	-2.50	2.40	13.70
EPS (Adj) (Unit Curr.)	6.04	16.81	5.16	-2.50	2.40	13.70
Calculated EPS (Unit Curr.)	6.04	16.81	5.16	-2.50	2.40	13.70
Calculated EPS (Adj) (Unit Curr.)	6.04	16.81	5.16	-2.50	2.40	13.70
Calculated EPS (Ann.) (Unit Curr.)	24.14	67.22	20.62	-9.99	9.60	54.80
Calculated EPS (Adj) (Ann.) (Unit Curr.)	24.14	67.22	20.62	-9.99	9.60	54.80
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	3.57	3.57	3.57	3.57	3.57	3.57
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	19.19	34.38	22.36	-8.04	9.66	25.37
PBDTM(%)	19.19	34.38	22.36	-8.22	9.22	24.94
PATM(%)	11.95	25.92	13.58	-7.78	3.48	19.03

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	3.57	3.57	3.57	3.57	3.57	3.57
Reserves Total	151.23	152.48	133.07	112.10	110.20	112.76
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	154.80	156.05	136.64	115.67	113.77	116.33
Secured Loans	0.00	0.00	0.00	0.00	0.00	1.74
Unsecured Loans	0.00	6.04	6.25	5.91	1.44	0.00
Total Debt	0.00	6.04	6.25	5.91	1.44	1.74
Total Liabilities	154.80	162.09	142.89	121.58	115.21	118.07
APPLICATION OF FUNDS :
Gross Block	50.74	47.07	42.74	41.80	40.57	37.76
Less : Accumulated Depreciation	25.47	23.29	21.30	19.24	17.35	15.44
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	25.27	23.78	21.44	22.56	23.22	22.32
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	1.72	0.50	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	41.29	46.18	33.18	24.87	28.06	44.98
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	12.50	18.36	21.67	19.30	16.17	17.55
Sundry Debtors	23.42	38.11	39.16	34.41	30.32	31.61
Cash and Bank	40.41	37.48	34.83	29.99	22.92	11.38
Loans and Advances	23.33	15.09	13.88	12.14	14.22	11.79
Total Current Assets	99.66	109.05	109.54	95.83	83.63	72.33
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	8.16	15.36	17.64	16.75	15.97	17.86
Provisions	3.69	4.12	3.67	2.42	0.62	0.60
Total Current Liabilities	11.86	19.47	21.31	19.17	16.59	18.46
Net Current Assets	87.80	89.57	88.23	76.66	67.05	53.87
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	2.54	2.58	2.52	2.96	3.47	3.18
Net Deferred Tax	-2.54	-2.58	-2.52	-2.96	-3.47	-3.18
Total Assets	151.81	158.67	140.83	121.13	114.87	117.98
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	2.51	2.32	1.11	2.97	1.80
Net Cash from Operating Activities	12.67	6.08	0.93	-3.86	-0.88
Net Cash Used In Investing Activities	-2.61	-6.05	-0.07	-1.55	3.23
Net Cash Used In Financing Activities	-6.43	0.15	0.35	3.56	-1.18
Net Inc./Dec In Cash And Cash Equivalents	3.62	0.18	1.21	-1.86	1.17
Cash And Cash Equivalents At End Of The Year	6.13	2.51	2.32	1.11	2.97

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

71.51%

FII Shareholding

0.14%

DII Shareholding

0.00%

Public Shareholding

28.35%

**Promoter pledged shareholding 71.51%

About Coral Laboratories Ltd

Coral Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 135.2 crores. It has reported a sales of Rs. 18.08 crores and a net profit of Rs. 2.16 crores for the quarter ended December 2018. The company management includes , Sheela R Kamdar,Girish Dhameja,Sushma Shashi Kadkade,Saurabh Shah,Malay Doshi,Rajendrasinh Rana,Ruchi Pipara (Coral Laboratories Ltd) among others.

Chairman

Registered office

SF-206 Silver Oak Complex,BPC Road,Vadodara,Gujarat,390020

FAX :

Background

Incorporation Year1981

Face Value₹10

Market Lot1

How to buy Coral Labs. shares on nse?

To buy Coral Labs. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Coral Labs. share price today?

The Coral Labs. shares price on nse is Rs.378.7 today.

What is the market cap of Coral Labs. shares on BSE ?

The company has a market capitalization of Rs.135.20Cr

What is the PE & PB ratio of Coral Labs. shares ?

PE is 14.76 and PB is 0.79

What is the 52 Week High and Low of Coral Labs. shares?

Coral Labs. stock price high: Rs.498.1 Coral Labs. stock price low: Rs.225